James V. Caruso
Net Worth

Last updated:

What is James V. Caruso net worth?

The estimated net worth of Mr. James V. Caruso is at least $8,522,647 as of 4 Mar 2021. He owns shares worth $406,949 as insider, has earned $40,698 from insider trading and has received compensation worth at least $8,075,000 in Cellectar Biosciences, Inc..

What is the salary of James V. Caruso?

Mr. James V. Caruso salary is $807,500 per year as Pres, Chief Executive Officer & Director in Cellectar Biosciences, Inc..

How old is James V. Caruso?

Mr. James V. Caruso is 66 years old, born in 1959.

What stocks does James V. Caruso currently own?

As insider, Mr. James V. Caruso owns shares in one company:

Company Title Shares Price per share Total value
Cellectar Biosciences, Inc. (CLRB) Pres, Chief Executive Officer & Director 86,401 $4.71 $406,949

What does Cellectar Biosciences, Inc. do?

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients; and Phase I study for various pediatric cancers, r/r head and neck cancers, and R/R MM. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative PDC programs with Avicenna Oncology GMBH to develop CLR 2000 Series; Orano Med to develop CLR 12120 Series; IntoCell Inc; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.

CLRB logo
CLRB
Cellectar Biosciences, Inc.
$4.71

James V. Caruso insider trading

Cellectar Biosciences, Inc.

Mr. James V. Caruso has made 2 insider trades between 2015-2021, according to the Form 4 filled with the SEC. Most recently he sold 46,948 units of CLRB stock on 4 Mar 2021.

The largest trade he's ever made was exercising 46,948 units of CLRB stock on 20 Apr 2016. As of 4 Mar 2021 he still owns at least 86,401 units of CLRB stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Series A Warrants 46,948 N/A N/A
Purchase
Common Stock 5,100 $1.7 $8,660
Purchase
Common Stock 37,037 $1.35 $50,000
Purchase
Common Stock 21,740 $1.15 $24,892
Purchase
Series H Warrants 10,870 $1.21 $13,131
Purchase
Common Stock, par value $0.00001 per share 1,000 $2.28 $2,282
Sale
Common Stock 34,000 $1.2 $40,698
Purchase
Series A Warrants 46,948 $3.04 $142,722
Purchase
Common Stock, par value $0.00001 per share 46,948 $3.04 $142,722
Purchase
Common Stock, par value $0.00001 per share 1,000 $1.3 $1,302
Purchase
Common Stock, par value $0.00001 per share 1,000 $1.16 $1,159
Purchase
Common Stock, par value $0.00001 per share 2,000 $1.5 $3,000
Purchase
Common Stock, par value $0.00001 per share 2,000 $1.5 $3,000

Cellectar Biosciences key executives

Cellectar Biosciences, Inc. executives and other stock owners filed with the SEC: